|
Arief
Gusnanto
My main research interest is in statistical inference of high-dimensional
data in molecular biology, genetics, gene and protein expression. I
am currently working in a project to discover genetic markers for the
prediction of thrombus formation in coronary artery disease. More information
can be obtained from my personal website.
Medical Research Council – Biostatistics Unit
Institute of Public Health
Robinson Way
Cambridge CB2 0SR
United Kingdom
Tel. +44 1223 767408
Fax. +44 1223 330388
Email Arief.Gusnanto@mrc-bsu.cam.ac.uk
http://www.mrc-bsu.cam.ac.uk/personal/arief
Magnus
Åberg
Research Activity:
My research is mainly focussed on method/algorithm development for data
analysis in the field of analytical chemistry in general, and metabolic
profiling in specific. In the metabolic profiling and other information
rich measurements there is a need to automate as much of the data analysis
as possible. For instance, it is not feasible to manually integrate
all the peaks in full-scan LC/MS runs on several hundred samples; there
are thousands of peaks in each sample. The part of the data analysis
that needs most to be automated is the pre-processing step where the
data are transformed so that every variable carries the same type of
information in all the samples. With the NMR and LC/MS platforms this
is not generally true; the locations of the peaks shift about due to
physicochemical differences between samples and instrumental irreproducibility.
Warping and peak alignment are methods that solves the problem with
peak shifts by using the local pattern to assign correspondence between
the variables in different samples.
Complete data analysis of a metabolic profiling dataset includes, in
addition to warping or peak alignment; peak detection, baseline estimation
and some statistical evaluation, for instance using Bayesian modelling,
at the end. My research addresses all these issues.
Teaching:
Lecturer and lab assistant at the Chemometrics course at Stockholm University,
yearly since 2000. The course teaches basic statistics and chemometrics,
with focus on design of experiments, principal component analysis (PCA)
and partial least squares regression (PLS).
Stockholm University
Dept. of Analytical chemistry
106 91 Stockholm
Sweden
Phone: +46-8-16 24 35
Email: magnus.aberg@anchem.su.se
Luisa
Bernardinelli
MRC Biostatistics Unit
Institute of Public Health
Forvie Site, Robinson Way
Cambridge CB2 2SR
United Kingdom
Ph. +44 (1223) 330300
Fax +44 (1223) 330388
Dipartimento di Scienze Sanitarie Applicate
Università di Pavia
Carlo
Berzuini
MRC Biostatistics Unit
Institute of Public Health
Forvie Site, Robinson Way
Cambridge CB2 2SR
United Kingdom
Ph. +44 (1223) 330300
Fax +44 (1223) 330388
Dipartimento di Informatica e Sistemistica
Università di Pavia
Via Ferrata 1, 27100 Pavia
Eduwin
Pakpahan
Dipartimento di Scienze Sanitarie Applicate
Università di Pavia
Via Bassi 21, 27100 Pavia
Email: eduwin.pakpahan@unipv.it
Chris
Holmes
I am lecturer in Statistical Genomics at the University of Oxford,
based in the Oxford Centre for Gene Function. My research concerns the
theory,
methods and applications of statistical modelling to the genomic sciences,
with particular interest in Bayesian statistics and genetic epidemiology.
I teach a number of post-graduate courses in Oxford on statistical bioinformatics.
Department
of Statistics
University of Oxford
Oxford Centre for Gene Function
Mammalian Genetic Unit MRC | Harwell
http://www.stats.ox.ac.uk/~cholmes/
Marc-Emmanuel
Dumas
Marc-Emmanuel Dumas is a Wellcome Trust Research Fellow
in the Department of Biomolecular Medicine, Imperial College London
(UK). He has been involved in all aspects of metabonomics data acquisition
and analysis since 1998. On the analytical side, he has focussed on
promoting multidimensional nuclear magnetic resonance (NMR) and metastable
atom bombardment mass spectrometry (MAB-MS) metabonomic strategies in
doping control during his PhD. On the statistical analysis side, he
has developed feature selection models, pattern recognition models for
epidemiology and insulin resistance research. His research interests
focus on applications of metabonomics to systems biology, chemical biology
and genetical genomics. He has been leading the metabonomics workpackage
of the Wellcome Trust funded Biological Atlas of Insulin Resistance
consortium since 2002. Marc has been involved in several courses on
metabonomics and will start his research group as associate professor
position in the new Ultra-High Field NMR centre at the Department of
Chemistry of Ecole Normale Supérieure de Lyon (Fr) in April 2007.
Department of Biomolecular Medicine, Division of Surgery, Oncology,
Reproductive Biology and Anaesthetics, Faculty of Medicine, Sir Alexander
Fleming Building, Exhibition Road, South Kensington, London SW7 2AZ,
United Kingdom.
Phone: +44 207 594 1698
Fax: +44 207 594 3226
Email: m.dumas@imperial.ac.uk
http://www1.imperial.ac.uk/medicine/people/m.dumas/
Mattias
Rantalainen
Mattias Rantalainen got a MSc in Engineering Biology (2003) at Umea
University. He is currently a PhD student at the Department of Biomolecular
Medicine, Imperial College London. His thesis research includes algorithm
development and application of multivariate statistical models for integration,
prediction and visualization of ``Omics’’ data.
Department of Biomolecular Medicine
Division of Surgery, Oncology, Reproductive Biology and Anaesthetics
(SORA)
Faculty of Medicine
Imperial College of Sciences, Technology and Medicine
Sir Alexander Fleming Building
Exhibition Road
South Kensington
London SW7 2AZ
Email:mattias.rantalainen (at) imperial.ac.uk
Jens Lamerz
Jens Lamerz worked on the biostatistical analysis of quantitative
Proteomics/Peptidomics data for the last five years. In this time, he
contributed to the implementation of data integration, data processing,
quality control and Biomarker Discovery. In his time at BioVisioN AG,
Hannover / ETH Zurich, his primary focus was the interpretation of
correlated signals in Peptidomics data and its use for Sequence algorithms
and Biomarker panels. He currently analyses bioassay features of SILAC
data at Roche RCMG.
Jens Lamerz, PhD,
F. Hoffmann-La Roche AG
Roche Center for Medical Genomics (RCMG)
Application Development BR
Bldg. 93 / 3.44
CH-4070 Basel
Tel. +41 61 6875183
Fax: +41 61 6881490
e-mail: jens.lamerz@roche.com
Philip
Brown
Phil Brown is Pfizer Professor of Medical Statistics and Head of
the
Statistics Group at the University of Kent. He is also Honorary Associate
in the Faculty of Medicine, Monash University, Melbourne Australia.
His PhD was in the area of multivariate analysis applied to drug discovery
and was completed whilst he was supported by Imperial Chemical Industries.
Since then he has worked extensively on chemometric problems culminating
in a book on regression and multivariate calibration in 1993. Most recently
he has been working
with researchers from the MD Anderson Cancer Center in Houston on Mass
Spectroscopy applied to proteomic data. He has taught at undergraduate
and graduate level in Imperial College, Liverpool University and University
of Kent in the UK. He has taught also in Berkeley (California), Helsinki,
Stockholm and Rome. International Honours include membership of the
Institute of Mathematical Statistics, Fellowship of American Statistical
Association and in 2003 he was recipient, with three co-authors, of
the Mitchell Prize for the best
applied Bayesian paper. He is on the Editorial advisory Board of Chemometrics
and Intelligent Laboratory Systems.
Philip J Brown, Pfizer Professor of Medical Statistics, Institute of
Maths,
Statistics and Actuarial Research, University of Kent, CT2 7NF, UK.
Email pjb8@kent.ac.uk
http://www.kent.ac.uk/ims/groups/statistics/members.htm
Richard
H. Barton
Richard is currently project leader for the Metabonomics
platform of the Centre for Integrated Systems Biology at Imperial College
(CISBIC). After a first degree in chemistry, he spent some years studying
psychology and philosophy of science and teaching logic, before returning
to chemistry to model electrode surface kinetics. This was followed
by a period of research in physical and analytical chemistry and an
AGMARDT PhD scholarship project involving development of techniques
in quantitative 13C NMR spectroscopy whilst in New Zealand. Subsequently,
after working in the UK Biotech industry and freelancing in Paris, he
took a position in what is now the Biomolecular Medicine section of
the Faculty of Medicine at Imperial College, London. In this role, he
has been involved in the ongoing development of Metabonomic technologies,
specifically including work in NMR-based data acquisition, signal correction,
and data filtering techniques aimed at enhancing information recovery
from high-field NMR biofluid spectroscopic data. Projects include modelling
in analytical methodology, toxicity prediction, molecular epidemiology,
and disease pathogenesis with particular reference to Type II Diabetes
with the Wellcome Trust Biological Atlas of Insulin Resistance consortium
project.
Research Fellow
Biomolecular
Medicine
Faculty of Medicine
and
Metabonomics platform project leader,
Centre
for Integrated Systems Biology at Imperial College (CISBIC)
Imperial College London
Sir Alexander Fleming Building
Exhibition Road,
London
SW7 2AZ
United
Kingdom.
Phone: +44 207 594 3014
Fax: +44 207 594 3226
Email: r.barton@ic.ac.uk
Bart
Mertens
Teaching:
Currently coordinating and teaching the course Clinical Research in
Practice for fourth year (Masters) students in Biomedical Science. The
course focuses on logistic regression and survival analysis in a strong
interdisciplinary context (joint with Dep. Epidemiology and Medical
Information Science).
Research:
My two main research interests at the moment are:
* development of statistical methods for diagnosis and prediction in
mass spectroscopy proteomics
* quality control and comparison methods in radiology
General research interest are in Bayesian methods, classification and
discriminant analysis, prediction, diagnosis and (cross-)validatory
analysis.
Department
of Medical Statistics and Bioinformatics
Leiden University Medical Centre
Leiden University
The Netherlands
Visiting
Address: LUMC, Einthovenweg 20, Leiden,
Postal Address: LUMC (Postal Zone S5-P), PO Box 9600, 2333 ZC Leiden
The Netherlands
Tel: +31 (0)71-526.9706
Fax: +31 (0)71-526.8280
Email
address: b.mertens@lumc.nl
Websites:
www.msbi.nl/mertens
www.lumc.nl
Cinzia
Stella
Cinzia Stella is currently a lecturer at the Laboratory of Pharmaceutics
and Bioinformatics at the University of Geneva (EPGL) – Switzerland.
She obtained her PhD in 2003 in Pharmaceutical Analytical Chemistry
at the University of Geneva and held a research associate position at
Imperial College – London (UK) in the field of metabonomics. Her
main expertise is the use of analytical tools, such as High (Ultra)
Performance Liquid Chromatography and High Resolution Nuclear Magnetic
Resonance Spectroscopy, for the analysis of biofluids and pharmaceutical
formulations. She has been involved in several collaborative projects
between industry and academia concerning the metabolic characterization
by H(U)PLC coupled to Mass Spectrometry of human biofluids, mainly in
nutritional studies.
Her teaching experience is the application of analytical and statistical
tools for Pharmacy students and metabonomic techniques for Medicine
students.
Cinzia Stella,
PhD
Laboratory of Pharmaceutics and Biopharmaceutics
EPGL – University of Geneva University of Lausanne
Quai Ernest Ansermet 30
CH-1211 Geneva 4 / Switzerland
Tel. : +41 (0)22 379 68 89
Fax : +41 (0)22 379 65 67
e-mail : Cinzia.Stella@pharm.unige.ch
Anthony
Maher
My research is mainly focussed on the application of NMR spectroscopy
to address biological questions. At present I am working at Imperial
College London on the metabonomics workpackage (WP2) of the MolPAGE
project. My role is to run 1H NMR experiments on urine and plasma samples
as part of a coordinated effort to understand type II diabetes on a
systems biology level.
Imperial College London
e-mail:
a.maher@imperial.ac.uk
Mark
Earll
Mark Earll is a consultant for Umetrics UK Ltd a software
company specialising in the visualisation and modelling of research
data using chemometric methods. Customers include major pharmaceutical
companies and academic researchers worldwide. Mark has previously worked
in pharmaceutical R&D as an analytical chemist with interests in
QSAR and ADMET modelling. Since joining Umetrics he has worked with
the application of chemometrics methods to "Omics" data for
both academic and industrial clients.
Umetrics UK Ltd
Woodside House
Woodside
Winkfield
Berkshire
SL4 2DX
e-mail : mark.earll@umetrics.com.uk
Bernard
Silverman
Bernard Silverman is Master of St Peter's College, Oxford
and
Professor of Statistics at Oxford University. His research ranges widely
over areas of methodological, theoretical and practical statistics,
but his main areas of interest are in smoothing methods, wavelets in
statistics, functional data analysis and, the subject of the current
talk, empirical Bayes methods for very high dimensional problems.
Oxford
University
email: bernard.silverman@spc.ox.ac.uk
web: www.bernardsilverman.com
Brian
D M Tom
Brian Tom is a statistician at the Medical Research Council Biostatistics
Unit since December 2001. His research areas are quite varied, ranging
from epidemiology to biostatistics and bioinformatics.He
is currently involved in projects on chronic diseases such as hepatitis
C virus, psoriatic arthritis, mental illnesses and cardiovascular disease.
His interests in the area of bioinformatics, have been mainly in the
area of microarrays (analysis, quality determination, and data fusion),
although he is presently involved on projects to do with pseudo-genes
and transcription binding site prediction. He is part of the statistical
team involved in the EU funded Bloodomics consortium whose aim is to
investigate the role of platelets and other blood cells in heart disease.
Medical
Research Council Biostatistics Unit Institute of Public Health University
Forvie Site Robinson Way
Cambridge CB2 2SR
United Kingdom
Tel no: +44 1223 330 395
Email : brian.tom@mrc-bsu.cam.ac.uk
Paul
Eilers
I’m an associate professor at the Methodology and Statistics
department of Utrecht University, but until very recently I worked at
the Department of Medical Statistics and Bioinformatics of the Leiden
University Medical Centre. I have been working with hig-throughput data
(expression microarrys, mass spectrometry, SNP, NMR) for the last seven
years. Being educated as an electronic engineer I have always had a
strong interest in signal processing. In many consulting projects I
have worked on a variety of (high-volume) chemical and physical measuremnts,
from laboratories or from the field. This has turned out to be very
useful in the bioinformatics arena: where data quality can be a real
problem (although this is often ignored by eager users). It has also
led to a number of papers in statistics, bioinformatics and chemometrics
journals, describing practical algorithms.
Dr. ing. Paul H. C. Eilers
tel.
(31) 30 253 4438
fax
(31) 30 253 5797
e-mail:
p.h.c.eilers@fss.uu.nl
Visiting
address:
Kamer
E347
Martinus
Langeveldgebouw
Heidelberglaan
1
3584
CS Utrecht
Postal
address (English)
Methodology
and Statistics
Faculty
of Social and Behavioural Sciences
Utrecht
University
P.O.
Box 80140
3508
TC Utrecht
The
Netherlands
Postal
address (Dutch)
Disciplinegroep
Methoden & Technieken
Faculteit
Sociale Wetenschappen
Universiteit
Utrecht
Postbus
80140
3508
TC Utrecht
Nathan
Edwards
Dr. Edwards received a Ph.D. in Operations Research from Cornell
University in 2001. Joining the Informatics Research group at Celera
Genomics, Dr. Edwards worked on SCOPE, for identifying peptides from
tandem mass spectra by searching protein sequence databases, and other
critical elements of the analysis infrastructure for Celera's high-throughput
proteomics facility. Moving to Applied Biosystems, still as part of
the Informatics Research group in 2002, he led research on algorithmic
and statistical issues arising in the analysis of proteomics biomarker
workflows and developed the Biomarker Toolbox prototype.
Since joining the Center for Bioinformatics and Computational Biology
at the University of Maryland, College Park, in 2004, Dr. Edwards' research
has focused on the discovery of novel peptides that characterize alternative
splicing, coding SNPs, and mutant protein isoforms, using genomic and
EST sequences; and on the rapid identification of microorganisms by
MALDI-TOF mass spectrometry and bioinformatics, in collaboration with
researchers at University of Maryland, College Park; and the Johns Hopkins
School of Public Health.
Dr Edwards co-teaches a course in Biological Mass Spectrometry with
Dr. Catherine Fenselau and co-directed a USHUPO short course, with Dr.
Akilesh Pandey, in 2005 and 2006, titled Bioinformatics for Proteomics.
Nathan Edwards, Ph.D.
Center for Bioinformatics and Computational Biology University of Maryland,
College Park, MD 20742
Email: nedwards@umiacs.umd.edu
George
Nicholson
I am a postdoctoral researcher in the data analysis section
of MolPAGE. Our role in MolPAGE is to analyse data sets produced from
a wide variety of molecular phenotyping platforms (e.g. Affymetrix gene
expression arrays, metabonomic NMR data, proteomic mass spectrometry
data). Our statistical remit can, broadly speaking, be split in two.
Our first goal is to characterise variation in data on a platform-specific
level. Understanding the sources of variability (e.g. genetic, biological,
environmental and experimental) inherent in the measurement of a molecular
phenotype is a key step in assessing the potential for stable, informative
biomarkers. Our second aim is that of biomarker discovery itself. Analysis
of data from samples drawn from large cohort studies will allow the
comparison of molecular profiles of individuals that are discordant
for diabetes-related clinical traits. We aim to discover molecular signatures
that are informative for diabetes diagnosis and prognosis. Cross-platform
data integration will feature prominently in the search for powerful
and stable biomarkers.
Department of Statistics, University of Oxford,
Email: nicholso@stats.ox.ac.uk
Ingileif
B. Hallgrimsdottir
I am a post-doctoral researcher in the Statistics Department at
the
University of Oxford. My research is focused on methods for
identification of biomarkers for disease in the context of proteomics
and
metabonomics. My background is in statistical genetics and I also work
on problems in genomewide association analysis.
Department of Statistics
University of Oxford
e-mail: ingileif@stats.ox.ac.uk
|